» Articles » PMID: 24365324

Clinical Pain in Schizophrenia: a Systematic Review

Overview
Journal J Pain
Specialties Neurology
Psychiatry
Date 2013 Dec 25
PMID 24365324
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Studies about clinical pain in schizophrenia are rare. Conclusions on pain sensitivity in people with schizophrenia are primarily based on experimental pain studies. This review attempts to assess clinical pain, that is, everyday pain without experimental manipulation, in people with schizophrenia. PubMed, PsycINFO, Embase.com, and Cochrane were searched with terms related to schizophrenia and pain. Methodological quality was assessed with the Mixed Methods Appraisal Tool. Fourteen studies were included. Persons with schizophrenia appear to have a diminished prevalence of pain, as well as a lower intensity of pain when compared to persons with other psychiatric diseases. When compared to healthy controls, both prevalence and intensity of pain appear to be diminished for persons with schizophrenia. However, it was found that this effect only applies to pain with an apparent medical cause, such as headache after lumbar puncture. For less severe situations, prevalence and intensity of pain appears to be comparable between people with schizophrenia and controls. Possible underlying mechanisms are discussed. Knowledge about pain in schizophrenia is important for adequate pain treatment in clinical practice.

Perspective: This review presents a valuable insight into clinical pain in people with schizophrenia.

Citing Articles

Distributions of recorded pain in mental health records: a natural language processing based study.

Chaturvedi J, Stewart R, Ashworth M, Roberts A BMJ Open. 2024; 14(4):e079923.

PMID: 38642997 PMC: 11033644. DOI: 10.1136/bmjopen-2023-079923.


Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder.

Roy B, Li J, Lally C, Akerman S, Sullivan M, Fratantonio J BMC Psychiatry. 2024; 24(1):244.

PMID: 38566055 PMC: 10986122. DOI: 10.1186/s12888-024-05676-5.


Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient.

Lommer K, Tutzer F, Hofer A Int Clin Psychopharmacol. 2024; 39(4):288-290.

PMID: 38170806 PMC: 11136262. DOI: 10.1097/YIC.0000000000000530.


Patterns of suboptimal antipsychotic use and misuse in Australia: What can routinely collected data tell us?.

Brett J, Gillies M, Buckley N, Pearson S, Zoega H Br J Clin Pharmacol. 2023; 89(11):3411-3420.

PMID: 37309058 PMC: 10953398. DOI: 10.1111/bcp.15821.


Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study.

van der Hoorn M, Kalkman G, Weesie Y, Atsma F, Schellekens A BJPsych Open. 2023; 9(3):e74.

PMID: 37078115 PMC: 10134259. DOI: 10.1192/bjo.2023.54.